JP2001523961A5 - - Google Patents

Download PDF

Info

Publication number
JP2001523961A5
JP2001523961A5 JP1998546437A JP54643798A JP2001523961A5 JP 2001523961 A5 JP2001523961 A5 JP 2001523961A5 JP 1998546437 A JP1998546437 A JP 1998546437A JP 54643798 A JP54643798 A JP 54643798A JP 2001523961 A5 JP2001523961 A5 JP 2001523961A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998546437A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001523961A (ja
JP4566290B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA1998/000394 external-priority patent/WO1998049311A2/en
Publication of JP2001523961A publication Critical patent/JP2001523961A/ja
Publication of JP2001523961A5 publication Critical patent/JP2001523961A5/ja
Application granted granted Critical
Publication of JP4566290B2 publication Critical patent/JP4566290B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP54643798A 1997-04-30 1998-04-30 癌、ウイルスまたは寄生虫感染を治療するためのリシン様毒素変異体 Expired - Lifetime JP4566290B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4514897P 1997-04-30 1997-04-30
US60/045,148 1997-04-30
US6371597P 1997-10-29 1997-10-29
US60/063,715 1997-10-29
PCT/CA1998/000394 WO1998049311A2 (en) 1997-04-30 1998-04-30 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections

Publications (3)

Publication Number Publication Date
JP2001523961A JP2001523961A (ja) 2001-11-27
JP2001523961A5 true JP2001523961A5 (cg-RX-API-DMAC7.html) 2007-01-11
JP4566290B2 JP4566290B2 (ja) 2010-10-20

Family

ID=26722431

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54643798A Expired - Lifetime JP4566290B2 (ja) 1997-04-30 1998-04-30 癌、ウイルスまたは寄生虫感染を治療するためのリシン様毒素変異体

Country Status (8)

Country Link
US (3) US6593132B1 (cg-RX-API-DMAC7.html)
EP (1) EP0977862B8 (cg-RX-API-DMAC7.html)
JP (1) JP4566290B2 (cg-RX-API-DMAC7.html)
AT (1) ATE437229T1 (cg-RX-API-DMAC7.html)
AU (1) AU7023798A (cg-RX-API-DMAC7.html)
CA (1) CA2288943C (cg-RX-API-DMAC7.html)
DE (1) DE69840998D1 (cg-RX-API-DMAC7.html)
WO (1) WO1998049311A2 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361946B1 (en) 1997-02-05 2002-03-26 Licentia Ltd Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
US7247715B2 (en) * 1997-04-30 2007-07-24 Twinstrand Therapeutics Inc. Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
AU7636800A (en) 1999-10-04 2001-05-10 Twinstrand Therapeutics Inc. Improved ricin-like toxins for treatment of cancer
GB0100551D0 (en) * 2001-01-09 2001-02-21 Queen Mary & Westfield College Protein
EP1483298A4 (en) 2002-02-11 2007-03-14 Zymogenetics Inc MATERIALS AND METHODS FOR PREPARING DIMERED GROWTH FACTORS
AU2004257206A1 (en) * 2003-07-10 2005-01-27 Wyeth Holdings Corporation Recombinant expression of Streptococcus pyogenes cysteine protease and immunogenic compositions thereof
EP1730282A4 (en) * 2004-03-24 2007-05-09 Twinstrand Therapeutics Inc GLYCOSYLATION VARIANTS OF RICINE-LIKE PROTEINS
ATE467641T1 (de) * 2004-03-26 2010-05-15 Molecular Templates Inc Bibliothek von toxin mutanten und deren verwendung
US20060024722A1 (en) * 2004-07-30 2006-02-02 Mark Fischer-Colbrie Samples for detection of oncofetal fibronectin and uses thereof
DE102005002978B4 (de) * 2005-01-21 2013-04-25 Merz Pharma Gmbh & Co. Kgaa Rekombinante Expression von Proteinen in einer disulfidverbrückten, zweikettigen Form
CA2664549A1 (en) 2005-09-26 2007-03-29 University Health Network Library from toxin mutants, and methods of using same
DE602006012358D1 (de) * 2005-11-18 2010-04-01 Dabur Pharma Ltd Zielgerichtete fusionsproteine für die krebstherapie
WO2008157263A2 (en) * 2007-06-15 2008-12-24 Arkansas State University Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same
EP2379720B1 (en) 2009-01-20 2016-08-17 Alona Zilberberg Mir-21 promoter driven targeted cancer therapy
US9321847B2 (en) * 2010-09-20 2016-04-26 Ramot At Tel Aviv University Ltd. Activatable toxin complexes comprising a cleavable inhibitory peptide
US10513539B2 (en) 2011-02-10 2019-12-24 Ruprecht-Karls-Universitat Heidelberg Hydrophobic modified peptides and their use for liver specific targeting
CN103402546B (zh) 2011-02-10 2018-04-13 海德堡鲁普雷希特卡尔斯大学 用于肝特异性诊断的疏水性修饰肽
WO2012123755A1 (en) 2011-03-17 2012-09-20 The University Of Birmingham Re-directed immunotherapy
JP7134461B2 (ja) * 2018-03-23 2022-09-12 国立大学法人金沢大学 マラリア治療剤、マラリア予防剤及び抗マラリア自然免疫賦活剤
KR102698801B1 (ko) 2020-12-30 2024-08-29 호크아이 바이오 리미티드 바이오마커 검출을 위한 순수 그래핀 기반 바이오센서 및 관련 코어 입자, 재료 구성 방법 및 시스템
TW202328170A (zh) * 2021-09-14 2023-07-16 美商艾希利歐發展股份有限公司 可裂解連接子
WO2025151752A1 (en) 2024-01-10 2025-07-17 Xilio Development, Inc. Masked il-2 cytokines and methods of use thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2442A (en) 1842-02-01 Floating dry-dock
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0145111B1 (en) * 1983-07-15 1990-05-09 The University Of Warwick Dna sequence coding for a plant toxin of the ricin type, or a portion thereof
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4869903A (en) 1987-05-29 1989-09-26 Genelabs Incorporated Method of selectively inhibiting HIV
WO1990010457A1 (en) 1989-03-14 1990-09-20 New York University Method of treating hiv infections using immunotoxins
US5128460A (en) 1989-04-04 1992-07-07 Genelabs Incorporated Recombinant trichosanthin and coding sequence
US5101025A (en) 1989-04-04 1992-03-31 Genelabs Incorporated Recombinant trichosanthin and coding sequence
US5248606A (en) * 1990-06-11 1993-09-28 Dowelanco Dna encoding inactive precursor and active forms of maize ribosome inactivating protein
GB9021679D0 (en) 1990-10-05 1990-11-21 Gorman Scott David Antibody preparation
US5677274A (en) * 1993-02-12 1997-10-14 The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services Anthrax toxin fusion proteins and related methods
EP0909322B1 (en) * 1996-04-30 2005-11-16 Twinstrand Therapeutics Inc. Antiviral ricin-like proteins

Similar Documents

Publication Publication Date Title
JP2001514563A5 (cg-RX-API-DMAC7.html)
JP2000507042A5 (cg-RX-API-DMAC7.html)
JP2000509942A5 (cg-RX-API-DMAC7.html)
JP2000510751A5 (cg-RX-API-DMAC7.html)
JP2000509637A5 (cg-RX-API-DMAC7.html)
JP2000509912A5 (cg-RX-API-DMAC7.html)
JP2000509587A5 (cg-RX-API-DMAC7.html)
JP2000507369A5 (cg-RX-API-DMAC7.html)
JP2000507433A5 (cg-RX-API-DMAC7.html)
JP2000508866A5 (cg-RX-API-DMAC7.html)
JP2000510793A5 (cg-RX-API-DMAC7.html)
JP2000508841A5 (cg-RX-API-DMAC7.html)
JP2001522369A5 (cg-RX-API-DMAC7.html)
JP2001511217A5 (cg-RX-API-DMAC7.html)
JP2001524148A5 (cg-RX-API-DMAC7.html)
JP2000508680A5 (cg-RX-API-DMAC7.html)
JP2000509853A5 (cg-RX-API-DMAC7.html)
JP2000509755A5 (cg-RX-API-DMAC7.html)
JP2002511070A5 (cg-RX-API-DMAC7.html)
JP2000510969A5 (cg-RX-API-DMAC7.html)
JP2001511717A5 (cg-RX-API-DMAC7.html)
JP2000510247A5 (cg-RX-API-DMAC7.html)
JP2000508102A5 (cg-RX-API-DMAC7.html)
JP2000508836A5 (cg-RX-API-DMAC7.html)
JP2000509520A5 (cg-RX-API-DMAC7.html)